B-NHL
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| An Evaluation of LY007 Cell Injection for r/r B-NHL (NCT06279611) | Shanghai Longyao Biotechnology Inc., Ltd. | 2021-12-25 |
| An Evaluation of LY007 Cell Injection for r/r B-NHL (NCT06364852) | Ruijin Hospital | 2021-12-25 |
| CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies (NCT03448393) | National Cancer Institute (NCI) | 2018-03-26 |
| Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies (NCT02315612) | National Cancer Institute (NCI) | 2014-12-12 |
Track B-NHL automatically
Every clearance here is in the API, with alerts when new ones post.